-
Je něco špatně v tomto záznamu ?
ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis
I. Hojsak, V. Colomb, C. Braegger, J. Bronsky, C. Campoy, M. Domellöf, N. Embleton, N. Fidler Mis, JM. Hulst, F. Indrio, A. Lapillonne, W. Mihatsch, C. Molgaard, J. van Goudoever, M. Fewtrell, . ,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, metaanalýza, přehledy
- MeSH
- cholestáza epidemiologie etiologie MeSH
- dítě MeSH
- hodnocení rizik MeSH
- jaterní testy MeSH
- kojenec MeSH
- lidé MeSH
- novorozenec MeSH
- parenterální výživa MeSH
- poradní výbory MeSH
- předškolní dítě MeSH
- randomizované kontrolované studie jako téma MeSH
- tukové emulze intravenózní aplikace a dávkování škodlivé účinky toxicita MeSH
- výsledek terapie MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- přehledy MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
The aim of the present article was to perform a systematic review with meta-analysis of available scientific evidence regarding the role of different intravenous lipid emulsions (ILE) in the pathogenesis of cholestasis and parenteral nutrition-associated liver disease. A systematic review of the literature (up to March 2015) identified 23 randomized controlled trials (RCTs). Of these, 17 were performed in preterm infants or critically ill neonates with a short duration of intervention, 2 in older children with short-term use (following surgery or bone marrow transplantation), 1 in neonates with long-term use, and 3 in infants and children receiving long-term parenteral nutrition (PN). Meta-analysis showed no differences in the rate of cholestasis or bilirubin levels associated with short-term use of different ILEs. Because of high heterogeneity of the long-term studies no meta-analysis could be performed. Available studies found that the use of multicomponent fish oil (FO)-containing ILE compared with pure soya bean oil (SO), ILE-reduced liver enzymes, and bilirubin levels in noncholestatic children on long-term PN and one other RCT found that FO-based ILE-reversed cholestasis in a proportion of patients. The ESPGHAN Committee on Nutrition concludes that there is no evidence of a difference in rates of cholestasis or bilirubin levels between different ILE for short-term use in neonates. The use of multicomponent FO-containing ILE may contribute to a decrease in total bilirubin levels in children with IF on prolonged PN. Well-designed RCTs are, however, lacking and long-term effects have not been determined.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011304
- 003
- CZ-PrNML
- 005
- 20180404142724.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPG.0000000000001121 $2 doi
- 035 __
- $a (PubMed)26825766
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hojsak, Iva $u *University Children's Hospital Zagreb, Zagreb, Croatia †Paris, France ‡University Children's Hospital, Zurich, Switzerland §Department of Paediatrics, University Hospital Motol, Prague, Czech Republic ||Department of Paediatrics, University of Granada, Granada, Spain ¶Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden #Newcastle Neonatal Service, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK **Department of Gastroenterology, Hepatology and Nutrition, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia ††Department of Pediatric Gastroenterology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands ‡‡Pediatric Gastroenterology Division, Ospedale Pediatrico Giovanni XXIII, University of Bari, Bari, Italy §§Paris Descartes University, APHP Necker-Enfants Malades Hospital, Paris, France ||||CNRC, Baylor College of Medicine, Houston, TX ¶¶Harlaching Hospital Department of Pediatrics, Munich Municipal Hospitals, Munich, Germany ##Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen ***Pediatric Nutrition Unit, Copenhagen University Hospital, Rigshospitalet, Denmark †††Department of Pediatrics, VU University Medical Center, Amsterdam ‡‡‡Department of Pediatrics, Emma Children's Hospital-AMC, Amsterdam, The Netherlands §§§Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK.
- 245 10
- $a ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis / $c I. Hojsak, V. Colomb, C. Braegger, J. Bronsky, C. Campoy, M. Domellöf, N. Embleton, N. Fidler Mis, JM. Hulst, F. Indrio, A. Lapillonne, W. Mihatsch, C. Molgaard, J. van Goudoever, M. Fewtrell, . ,
- 520 9_
- $a The aim of the present article was to perform a systematic review with meta-analysis of available scientific evidence regarding the role of different intravenous lipid emulsions (ILE) in the pathogenesis of cholestasis and parenteral nutrition-associated liver disease. A systematic review of the literature (up to March 2015) identified 23 randomized controlled trials (RCTs). Of these, 17 were performed in preterm infants or critically ill neonates with a short duration of intervention, 2 in older children with short-term use (following surgery or bone marrow transplantation), 1 in neonates with long-term use, and 3 in infants and children receiving long-term parenteral nutrition (PN). Meta-analysis showed no differences in the rate of cholestasis or bilirubin levels associated with short-term use of different ILEs. Because of high heterogeneity of the long-term studies no meta-analysis could be performed. Available studies found that the use of multicomponent fish oil (FO)-containing ILE compared with pure soya bean oil (SO), ILE-reduced liver enzymes, and bilirubin levels in noncholestatic children on long-term PN and one other RCT found that FO-based ILE-reversed cholestasis in a proportion of patients. The ESPGHAN Committee on Nutrition concludes that there is no evidence of a difference in rates of cholestasis or bilirubin levels between different ILE for short-term use in neonates. The use of multicomponent FO-containing ILE may contribute to a decrease in total bilirubin levels in children with IF on prolonged PN. Well-designed RCTs are, however, lacking and long-term effects have not been determined.
- 650 _2
- $a poradní výbory $7 D026683
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a cholestáza $x epidemiologie $x etiologie $7 D002779
- 650 _2
- $a Evropa $x epidemiologie $7 D005060
- 650 _2
- $a tukové emulze intravenózní $x aplikace a dávkování $x škodlivé účinky $x toxicita $7 D005217
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a jaterní testy $7 D008111
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a parenterální výživa $7 D010288
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Colomb, Virginie
- 700 1_
- $a Braegger, Christian
- 700 1_
- $a Bronsky, Jiri
- 700 1_
- $a Campoy, Cristina
- 700 1_
- $a Domellöf, Magnus
- 700 1_
- $a Embleton, Nicholas
- 700 1_
- $a Fidler Mis, Nataša
- 700 1_
- $a Hulst, Jessie M
- 700 1_
- $a Indrio, Flavia
- 700 1_
- $a Lapillonne, Alexandre
- 700 1_
- $a Mihatsch, Walter
- 700 1_
- $a Molgaard, Christian
- 700 1_
- $a van Goudoever, Johannes
- 700 1_
- $a Fewtrell, Mary
- 700 1_
- $a ,
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 62, č. 5 (2016), s. 776-92
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26825766 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142804 $b ABA008
- 999 __
- $a ok $b bmc $g 1288789 $s 1008116
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 62 $c 5 $d 776-92 $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- LZP __
- $a Pubmed-20180404